Total Valuation
Elevance Health has a market cap or net worth of CHF69.41B. The enterprise value is $107.15B.
Market CapCHF69.41B
Enterprise Value$107.15B
Share Statistics
Elevance Health has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders0.17%
Owned by Institutions26.43%
Financial Efficiency
Elevance Health’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 6.65%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)6.65%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee1.91M
Profits Per Employee54.33K
Employee Count104,200
Asset Turnover1.64
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Elevance Health is 16.5. Elevance Health’s PEG ratio is -5.70.
PE Ratio16.5
PS Ratio0.39
PB Ratio1.77
Price to Fair Value1.77
Price to FCF24.50
Price to Operating Cash Flow11.25
PEG Ratio-5.70
Income Statement
In the last 12 months, Elevance Health had revenue of 199.13B and earned 5.66B in profits. Earnings per share was 25.18.
Revenue199.13B
Gross Profit50.90B
Operating Income8.11B
Pretax Income6.71B
Net Income5.66B
EBITDA9.66B
Earnings Per Share (EPS)25.18
Cash Flow
In the last 12 months, operating cash flow was 7.61B and capital expenditures -1.16B, giving a free cash flow of 6.45B billion.
Operating Cash Flow7.61B
Free Cash Flow6.45B
Free Cash Flow per Share10.00T>
Dividends & Yields
Elevance Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta―
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Elevance Health upcoming earnings date is Jul 22, 2026, Before Open (Confirmed).
Last Earnings DateApr 22, 2026
Next Earnings DateJul 22, 2026
Ex-Dividend Date―
Financial Position
Elevance Health as a current ratio of 1.24, with Debt / Equity ratio of 72.53%
Current Ratio1.24
Quick Ratio1.24
Debt to Market Cap0.42
Net Debt to EBITDA2.46
Interest Coverage Ratio5.79
Taxes
In the past 12 months, Elevance Health has paid 1.05B in taxes.
Income Tax1.05B
Effective Tax Rate0.16
Enterprise Valuation
Elevance Health EV to EBITDA ratio is 10.51, with an EV/FCF ratio of 31.98.
EV to Sales0.51
EV to EBITDA10.51
EV to Free Cash Flow31.98
EV to Operating Cash Flow23.66
Balance Sheet
Elevance Health has CHF35.56B in cash and marketable securities with CHF31.84B in debt, giving a net cash position of CHF3.72B billion.
Cash & Marketable SecuritiesCHF35.56B
Total DebtCHF31.84B
Net CashCHF3.72B
Net Cash Per ShareCHF10.00T>
Tangible Book Value Per ShareCHF20.21
Margins
Gross margin is 23.16%, with operating margin of 4.07%, and net profit margin of 2.84%.
Gross Margin23.16%
Operating Margin4.07%
Pretax Margin3.37%
Net Profit Margin2.84%
EBITDA Margin4.85%
EBIT Margin4.07%
Analyst Forecast
The average price target for Elevance Health is CHF336.91, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetCHF336.91
Price Target Upside― Downside
Analyst ConsensusModerate Buy
Analyst Count18
Revenue Growth Forecast―
EPS Growth Forecast―